Le Lézard
Classified in: Ebola virus, Health
Subject: SVY

New Study Validates Importance of Implementation and Utilization of UV Disinfection Technology


MEMPHIS, Tenn., Nov. 15, 2017 /PRNewswire/ -- A new study has been published regarding Tru-D and its deployment at Virginia Commonwealth University Health System (VCU). The study, Deployment of a touchless ultraviolet light robot for terminal room disinfection: The importance of audit and feedback, appeared online recently in the American Journal of Infection Control.

The study was conducted at VCU, an urban, 865-bed, academic medical center with private and semiprivate rooms. Data was collected during a 25-month period from February 1, 2015-February 28, 2017. During the study, there were 420,394 patient days and 99,184 admissions. In the study, VCU set a goal of 90% utilization of the Tru-D robots for high risk rooms. Through Tru-D's real-time usage-tracking features and by educating environmental services (ES) on the importance of patient safety, VCU achieved 100% utilization. The study stated, "The deployment was performed with structured education, audit and feedback, and resulted in a multidisciplinary practice change that maximized the UV disinfection capture rate from 20% to 100%." From February 2015 until January 2017, two Tru-D robots were used, and in mid-January 2017, two additional robots were purchased.

"This study is a testament to the process of implementing a successful UV disinfection program and maximizing utilization," said Alice Brewer, Director of Clinical Affairs for Tru-D SmartUVC. "VCU was ultimately able to achieve 100 percent utilization on the highest risk rooms due to Tru-D's data portal along with our strategic approach to Program Management."

An automated, no-touch disinfection robot, Tru-D is brought into a room after the ES staff cleans using traditional methods. Tru-D then operates from one position in the room and administers one cycle of UVC light, destroying up to 99.9 percent of harmful pathogens that can remain behind such as C. diff, MRSA, MERS, VRE, Ebola and many others. Tru-D delivers disinfection data to a secure myTru-D portal, allowing for real-time documentation of the disinfection process, putting critical data directly in the hands of operators and administrators. Once the cycle is finished, Tru-D alerts the operator via audio and/or text message that disinfection is complete and can be moved to the next room.

Validated by more than a dozen independent studies including the only randomized clinical trial on UV disinfection, Tru-D's technology has been proven by science to provide a safer patient environment. To learn more or to read independent studies, visit Tru-D.com. To watch a video on Tru-D's technology, visit tru-dpowerofone.com.

About Tru-D SmartUVC
Only Tru-D delivers an automated, measured dose of UVC light to consistently disinfect an entire room during one cycle. Operating from one position in the room, Tru-D ensures significant pathogen reduction in direct and shadowed areas. Validated by more than a dozen independent studies, Tru-D's automated, measured dosing capabilities and real-time usage-tracking features make it one of the most advanced UV disinfection systems available. To learn more and to watch a video on Tru-D's technology, visit tru-dpowerofone.com.

Media Contact:

Christin Yates                                  
Public Relations                             
Tru-D SmartUVC                            
901-774-5771                                   
[email protected]

SOURCE Tru-D SmartUVC


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: